Literature DB >> 4134468

Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D.

J G Levin, P M Grimley, J M Ramseur, I K Berezesky.   

Abstract

Production of particles with the ultrastructural appearance of C-type virions persisted for at least 6 h in actinomycin D-treated cells infected with murine leukemia virus. This phenomenon occurred despite severe inhibition of viral RNA synthesis. Virus particles present in a 6-h harvest sedimented in sucrose gradients with the buoyant density characteristic of RNA tumor viruses (1.16 g/cm(3)) and exhibited high levels of reverse transcriptase activity in response to the exogenous template polyriboadenylic acid.oligo deoxythymidylic acid in the range of untreated controls. However, RNase-sensitive endogenous activity was only (1/5) the level found in controls. This observation correlated with a marked reduction in infectivity. Kinetic studies on the appearance of labeled RNA in banded virions revealed that within the first hour after addition of actinomycin D, particles contained 60 to 70S RNA and two low-molecular-weight RNA species corresponding to 8 and 4S RNA. After approximately 1 h of incubation with actinomycin D, 60 to 70S RNA could not be detected and 4S RNA was the predominant species. These findings suggest that murine leukemia virus particles assembled in the presence of actinomycin D are deficient in 60 to 70S viral RNA.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4134468      PMCID: PMC355489     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  An RNA fraction from myeloblastosis virus having properties similar to transfer RNA.

Authors:  J W Carnegie; A O Deeney; K C Olson; G S Beaudreau
Journal:  Biochim Biophys Acta       Date:  1969-10-22

2.  Synthesis of the RNA of RNA-containing tumor viruses. I. The interval between synthesis and envelopment.

Authors:  J P Bader
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

3.  RNA with amino acid-acceptor activity isolated from an oncogenic virus.

Authors:  M Trávnícek
Journal:  Biochim Biophys Acta       Date:  1968-10-29

4.  Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus.

Authors:  R A Bonar; L Sverak; D P Bolognesi; A J Langlois; D Beard; J W Beard
Journal:  Cancer Res       Date:  1967-06       Impact factor: 12.701

5.  Complement fixation and tissue culture assays for mouse leukemia viruses.

Authors:  J W Hartley; W P Rowe; W I Capps; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1965-05       Impact factor: 11.205

6.  Protein synthesis directed by an arbovirus.

Authors:  R M Friedman
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

7.  Inhibition of Rauscher murine leukemia virus growth in vitro by actinomycin D.

Authors:  R E Bases; A S King
Journal:  Virology       Date:  1967-06       Impact factor: 3.616

8.  Inhibition of mouse leukemia virus (MLV) replication by actinomycin D.

Authors:  P H Duesberg; W S Robinson
Journal:  Virology       Date:  1967-04       Impact factor: 3.616

9.  Infection of an established mouse bone marrow cell line (JLS-V9) with Rauscher and Moloney murine leukemia viruses.

Authors:  B S Wright; P A O'Brien; G P Shibley; S A Mayyasi; J C Lasfargues
Journal:  Cancer Res       Date:  1967-09       Impact factor: 12.701

10.  Incorporation of precursors into ribonucleic acid, protein, glycoprotein, and lipoprotein of avian myeloblastosis virions.

Authors:  M A Baluda; D P Nayak
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  95 in total

1.  RNA is a structural element in retrovirus particles.

Authors:  D Muriaux; J Mirro; D Harvin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 5.  Destiny of unspliced retroviral RNA: ribosome and/or virion?

Authors:  Melinda Butsch; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Role of RNA in facilitating Gag/Gag-Pol interaction.

Authors:  Ahmad Khorchid; Rabih Halwani; Mark A Wainberg; Lawrence Kleiman
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells.

Authors:  M Butsch; K Boris-Lawrie
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 8.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

9.  Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Authors:  W Fu; R J Gorelick; A Rein
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.